Antidepressant use contributes to population weight gain

2018 ◽  
Vol 1704 (1) ◽  
pp. 6-6
BMJ Open ◽  
2017 ◽  
Vol 7 (8) ◽  
pp. e016224 ◽  
Author(s):  
Zumin Shi ◽  
Evan Atlantis ◽  
Anne W Taylor ◽  
Tiffany K Gill ◽  
Kay Price ◽  
...  

ObjectiveTo examine the association between antidepressant use and weight gain, as well as the interaction with lifestyle factors.DesignLongitudinal study.Setting and participantsWe used data from 2334 adults from two stages (4.4 years apart) of the North West Adelaide Health Study, including validated diet and lifestyle questionnaires, measured body weight and linked pharmaceutical prescription data.Main outcome measuresBody weight change.Results188 (8.1%) participants had a mean annual number of 1–2 antidepressant prescriptions, and 212 (9.1%) had over two prescriptions. The mean annual weight gain was 0.12, 0.18 and 0.28 kg in non-users, low (1–2 prescriptions/year) and high (>2 prescriptions/year) antidepressant users, respectively. In multivariable regression models, antidepressant use was positively associated with weight gain: high antidepressant users gained an extra 0.22 (95% CI 0.00 to 0.44) kg per year. This association was mainly due to selective serotonin reuptake inhibitor (SSRI) use. High SSRI users gained 0.48 (95% CI 0.20 to 0.76) kg more than non-users. There was no association between tricyclic or other antidepressant use and weight gain. The association between SSRI use and weight gain was stronger among those with high intake of Western diet, greater sedentary activity, and who smoked.ConclusionsSSRIs use was associated with weight gain in the presence of unhealthy behaviours including Western diet, sedentarism and smoking.


Author(s):  
Paige D. Wartko ◽  
Noel S. Weiss ◽  
Daniel A. Enquobahrie ◽  
Kwun Chuen Gary Chan ◽  
Alyssa Stephenson-Famy ◽  
...  

Objective Both excessive and inadequate gestational weight gain (GWG) are associated with adverse health outcomes for the woman and her child. Antidepressant use in pregnancy could affect GWG, based on evidence in nonpregnant women that some antidepressants may cause weight gain and others weight loss. Previous studies of antidepressant use and GWG were small with limited ability to account for confounding, including by maternal mental health status and severity. We assessed the association of antidepressant continuation in pregnancy with GWG among women using antidepressants before pregnancy. Study Design Our retrospective cohort study included singleton livebirths from 2001 to 2014 within Kaiser Permanente Washington, an integrated health care system. Data were obtained from electronic health records and linked Washington State birth records. Among women with ≥1 antidepressant fill within 6 months before pregnancy, women who filled an antidepressant during pregnancy were considered “continuers;” women without a fill were “discontinuers.” We calculated mean differences in GWG and relative risks (RR) of inadequate and excessive weight gain based on Institute of Medicine guidelines. Using inverse probability of treatment weighting with generalized estimating equations, we addressed differences in maternal characteristics, including mental health conditions. Results Among the 2,887 births, 1,689 (59%) were to women who continued antidepressants in pregnancy and 1,198 (42%) were to discontinuers. After accounting for confounding, continuers had similar weight gain to those who discontinued (mean difference: 1.3 lbs, 95% confidence interval [CI]: −0.1 to 2.8 lbs) and similar risks of inadequate and excessive GWG (RR: 0.95, 95% CI: 0.80–1.14 and RR: 1.06, 95% CI: 0.98–1.14, respectively). Findings were comparable for specific antidepressants and trimesters of exposure. Conclusion We did not find evidence that continuation of antidepressants in pregnancy led to differences in GWG. Key Points


2014 ◽  
Vol 71 (8) ◽  
pp. 889 ◽  
Author(s):  
Sarah R. Blumenthal ◽  
Victor M. Castro ◽  
Caitlin C. Clements ◽  
Hannah R. Rosenfield ◽  
Shawn N. Murphy ◽  
...  

2015 ◽  
Vol 4 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Michelle Crino ◽  
Gary Sacks ◽  
Stefanie Vandevijvere ◽  
Boyd Swinburn ◽  
Bruce Neal

2004 ◽  
Vol 24 (5) ◽  
pp. 555-556 ◽  
Author(s):  
Thomas L. Schwartz ◽  
Shefali Jindal ◽  
Mihai Simionescu ◽  
Nikhil Nihalani ◽  
Nouman Azhar ◽  
...  

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1148-1148
Author(s):  
Juliana Toro ◽  
Lais Botelho ◽  
Adriana Campa ◽  
Cristina Palacios

Abstract Objectives Depression and use of antidepressants in U.S. adolescents and young adults are becoming more prevalent. Antidepressant use may lead to higher energy intake and obesity; however, the evidence is not clear. Our objective was to assess whether energy intake and obesity differ between U.S. adolescents and young adults on antidepressants and those who are not. Methods Data from the NHANES 2015–2016 on prescription medication use, energy intake and weight status were obtained for participants 10–34 years. Inclusion criteria were completion of two dietary recalls, not underweight and non-pregnant women. Energy intake between users and non-users of antidepressants was compared using ANCOVA, adjusting for age, gender, BMI, and use of weight loss or weight gain diets and for obesity prevalence, we used Chi-square. Results The sample consisted of 802 adolescents (10–17 years) and 1126 young adults (18–34 years), with 50.7% female and 32.4% Hispanic, 27.9% White, 22.6% Black, 22.4% Multi-racial/other and 11.7% Asian. Obesity was 15.7% in adolescents and 35.1% in young adults and use of antidepressants was 2.4% in adolescents and 4.3% in young adults. Energy intake was higher among antidepressants’ users (2208 ± 780 kcals) compared to non-users (1982 ± 718 kcals; P < 0.001) after adjusting for age, gender, BMI, and weight loss/gain diet. In adolescents, energy intake was higher among antidepressants’ users (2145 ± 951 kcals) compared to non-users (1898 ± 676 kcals; P < 0.001). In young adults, energy intake was higher among users of antidepressants (2233 ± 712 kcals vs. non-users 2044 ± 742 kcals; P < 0.001). Obesity prevalence was higher among users (40.3% vs. non-users 26.5%, P = 0.038). When the two age groups were independently analyzed, obesity in young adults was significantly higher among users (47.9% vs. non-users 34.5%, P = 0.016), however, obesity in adolescents was not significantly different between groups (21.1% users vs.15.6% non-users, P = 0.682). Conclusions In this study, the use of antidepressants was associated with higher energy intake and higher prevalence of obesity, mainly in young adults. These results could be relevant when providing nutrition counseling to adolescents and young adults receiving pharmaceutical treatment for depression to help prevent excess energy intake and weight gain. Funding Sources FIU internal funds.


2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Erin Graves ◽  
David J. Hill ◽  
Susan Evers ◽  
Kristine Van Aarsen ◽  
Brie Yama ◽  
...  

Objective. Factors linked with insulin resistance were examined for their association with large-for-gestational-age (LGA) infant birth weight and gestational diabetes.Study Design. Data came from a longitudinal cohort study of 2,305 subjects without overt diabetes, analyzed using multinomial logistic and linear regression.Results. High maternal BMI (OR=1.53(1.11, 2.12)), height (1.98 (1.62, 2.42)), antidepressant use (1.71 (1.20, 2.44)), pregnancy weight-gain exceeding 40 pounds (1.79 (1.25, 2.57)), and high blood sugar (2.68, (1.53, 5.27)) were all positively associated with LGA birth. Strikingly, the difference in risk from diagnosed and treated gestational diabetes compared to women with a single abnormal glucose tolerance test (but no diagnosis of gestational diabetes) was significant (OR=0.65,p=0.12versusOR=2.84,p<0.01). When weight/length ratio was used instead, different factors were found to be significant. BMI and pregnancy weight-gain were found to influence the development of gestational diabetes, through an additive interaction.Conclusions. High prepregnancy BM, height, antidepressant use, pregnancy weight-gain exceeding 40 pounds, and high blood sugar were associated with LGA birth, but not necessarily infant weight/length ratio. An additive interaction between BMI and pregnancy weight-gain influenced gestational diabetes development.


2014 ◽  
Vol 62 ◽  
pp. 193-200 ◽  
Author(s):  
Luke Wolfenden ◽  
Rebecca Wyse ◽  
Melanie Nichols ◽  
Steven Allender ◽  
Lynne Millar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document